NeoDynamics Investor Relations Material

Latest events

Q1 2024

7 May, 2024

Q4 2023

16 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from NeoDynamics

Access all reports
NeoDynamics AB is a Swedish medical technology company focused on advancing cancer diagnosis and treatment. The company's flagship product, NeoNavia, is an innovative biopsy system designed for precise, ultrasound-guided tissue sampling. Built on patented pulse technology, NeoNavia enables controlled needle insertion and accurate placement within tumors, particularly for diagnosing breast cancer and axillary lymph nodes. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.